Alignment Healthcare, INC 8-K filings

Alignment Healthcare reported strong second quarter 2026 results, exceeding guidance across key metrics and raising full-year outlook.

Alignment Healthcare, Inc. held its annual stockholder meeting on June 4, 2026, where directors were elected and the appointment of Deloitte & Touche LLP was ratified.

Alignment Healthcare announced leadership changes, including the CEO assuming the Chairman role and new appointments for COO and President of MSO, to support long-term growth and operational scaling.

Alignment Healthcare's selling stockholder, General Atlantic, completed an underwritten secondary offering of 13.17 million shares of common stock, with the company receiving no proceeds.

Alignment Healthcare, Inc. reported strong fourth quarter and full-year 2025 financial results, exceeding guidance across all key metrics and raising 2026 membership and revenue outlook.

Alignment Healthcare announced robust 31% year-over-year membership growth and reaffirmed its 2025 financial guidance, projecting strong 2026 profitability.

Alignment Healthcare reported strong third-quarter 2025 financial results, surpassing guidance across all key metrics and raising its full-year outlook.

Alignment Healthcare, Inc. senior leaders are meeting with investors and analysts to discuss strategy, market position, recent results, and preliminary 2026/2027 Medicare Advantage Star ratings, reaffirming expectations for 100% of membership in 4 Star or higher plans.

Alignment Healthcare, Inc. reported robust second-quarter 2025 financial results, exceeding guidance across all key metrics and raising its full-year outlook, driven by significant growth in revenue and health plan membership.

Alignment Healthcare, Inc. announced the results of its 2025 Annual Meeting, where shareholders elected Class I directors, ratified Deloitte & Touche LLP as independent auditors, and approved executive compensation.

Alignment Healthcare exceeded expectations in Q1 2025, reporting a 47.5% year-over-year revenue increase and raising its 2025 guidance, while also announcing a CFO transition.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, has resigned, effective immediately, but will remain with the company until May 16, 2025, to assist with the transition.

Alignment Healthcare concludes a stockholder lawsuit by paying $950,000 in attorney fees and expenses, without admitting fault.

Alignment Healthcare announces a 58.6% year-over-year increase in health plan members, achieves its first full year of positive adjusted EBITDA, and provides robust financial guidance for 2025.

Alignment Healthcare reports a 35% year-over-year increase in health plan membership and promotes Dawn Maroney to President.

Alignment Healthcare successfully closed a $330 million convertible senior notes offering, using the proceeds to repay an existing term loan and for general corporate purposes.

Alignment Healthcare has entered into agreements to issue $330 million in convertible senior notes to lower its cost of capital and for general corporate purposes.

Alignment Healthcare announced a 51.6% year-over-year increase in total revenue and a 57.7% increase in Medicare Advantage membership, exceeding expectations for the third quarter of 2024.

Alignment Healthcare has announced the resignation of two board members and a subsequent consulting agreement with one of the departing directors.

Alignment Healthcare announced a 47.3% year-over-year revenue increase and a 56.1% jump in Medicare Advantage membership, exceeding expectations and leading to an increased full-year outlook.

Alignment Healthcare has borrowed $50 million in delayed draw term loans to enhance its balance sheet and provide future flexibility.

Alignment Healthcare's stockholders approved an amendment to the company's charter to limit officer liability and elected four Class III directors at its annual meeting on June 7, 2024.

Alignment Healthcare reports significant membership growth and improved cost management, positioning the company for continued success in 2024 and beyond.

Alignment Healthcare's first quarter results show significant year-over-year growth in revenue and membership, exceeding expectations and leading to an increased outlook for the year.

Alignment Healthcare announced a 27.2% increase in full-year 2023 revenue to $1.82 billion and projects continued growth in 2024 with adjusted EBITDA breakeven at the midpoint of the outlook ranges.